Skip to main content
SCPX logo

SCPX · Scorpius Holdings, Inc.

Track SCPX — free
$0.00 +0.00 (+0.00%) At close · Aug 14
Market Cap
$61,142
Shares
61.14M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$6.24M -10.7%
FY2024 Revenue FY2012–FY2024
Net Income
-$32.81M +27.4%
FY2024 Net Income FY2009–FY2024
Gross Margin
48.8% -12.1pp
FY2024 Gross Margin FY2022–FY2024
Operating Margin
-538.21% +62.7pp
FY2024 Operating Margin FY2012–FY2024
Diluted EPS
-$13.04 +96.2%
FY2024 Diluted EPS FY2020–FY2024
Operating Cash Flow
-$26.01M +17.5%
FY2024 Operating Cash Flow FY2012–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$1.72M $6.24M $6.99M $370.18K $2.11M $2.95M $3.05M $5.79M $1.52M $341.64K $3110
$38.72K $40.57K $10.07K
$987.25K $10.07K $2
$1.3M $3.2M $2.74M $81.3K
$413.14K $3.05M $4.26M $288.88K
48.8% 60.87% 78.04%
$10.96M $14.33M $20.12M $20.22M $16.46M $12.94M $13.01M $16.23M $8.27M $9.33M $16.67M $2.86M $2.74M $902.94K
$25.68M $21.13M $16.83M $14.93M $9.43M $7.03M $6.37M $4.14M $4.36M $3.98M $2.43M $1.19M
$15.27M $21.57M $26.17M $20.13M
$1.09M $1.03M
$7.15M $6.47M $2.12M $607.67K $333.15K $232.51K $237.32K
$39.63M $37.53M $29.07M $23.79M $23.75M $14.86M $13.47M $21.02M $12.19M $6.56M $2.35M
$35.36M $39.84M $49.03M $40.59M $37.53M
-$33.64M -$33.6M -$42.03M -$40.22M -$35.42M -$26.12M -$20.75M -$17.96M -$13.34M -$13.13M -$21.02M -$12.19M -$6.56M -$2.34M
-538.21% -600.9% -10865.82% -1676.4% -886.18% -680.39% -309.99% -877.85% -3842.41% -75327.23%
-$26.45M -$35.56M -$38.11M -$34.81M -$25.79M -$20.51M -$17.72M
$549.4K $363.63K $41K $79.12K $101.09K
$364K $73K
$7M -$727.53K -$301.43K -$1.37M -$127.74K -$257.03K $406.27K $383.53K $123.44K $152.52K -$99.17K -$56K -$45.22K -$108.34K
-$26.65M -$34.33M -$42.33M -$41.59M -$35.55M -$26.38M -$20.34M -$17.58M -$13.22M -$12.97M
-$571.12K -$215.94K -$145.97K $45.18K -$985.49K -$809.54K
-$25.18M -$32.81M -$45.22M -$43.43M -$35.07M -$26.05M -$20.02M -$15.73M -$11.84M -$12.57M -$20.3M -$11.79M -$9.07M -$2.42M -$2.11M -$721.84K -$423.44K
-525.51% -646.44% -11733.53% -1659.95% -883.65% -656.51% -271.56% -779.09% -3680.44% -77819.94%
-$1.47M -$1.52M -$1.62M -$427.49K -$329.34K -$331.65K -$367.15K -$857.44K -$568.2K -$400.85K -$826.63K -$454K -$198.52K -$50.95K
-$25.09M -$32.63M -$45.22M -$43.31M -$34.97M -$26.2M -$20.01M -$15.59M -$11.94M -$12.56M -$20.38M -$11.79M
USD/shares -$13.04 -$347.50 -$340.00 -$282.00 -$326.00
USD/shares -$13.04 -$347.50 -$340.00 -$282.00 -$326.00
shares 2.52M 130.12K 128.03K 124.57K 79.91K 23.77K 12.49K 2746.6729 1256.1579 5725.4907 4610.6186 2676.6836 1308.4064
shares 2.52M 130.12K 128.03K 124.57K 79.91K 23.77K 12.49K 2746.6729 1256.1579 5725.4907 4610.6186 2676.6836 1308.4064
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Biotechnology median 4.98×
EV/EBIT
Biotechnology median 22.76×
P/E (TTM)
Biotechnology median 16.97×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2022 FY2021
Product $5,980,993
Grant $402,176 $2,112,806
Key facts CIK 1476963 CUSIP 42237K508 Visit website